Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

Passage BIO, Inc. (PASG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Investor presentation, Quarterly results
Docs: ")",
"Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1study"
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/31/2023 8-K Quarterly results
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/20/2023 8-K Quarterly results
06/29/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Passage BIO, Inc.
Txns: Bought 617,382 shares @ $0.84, valued at $518.6k
Bought 575,195 shares @ $0.84, valued at $483.2k
06/29/2023 SC 13D/A ORBIMED ADVISORS LLC reports a 14.7% stake in Passage BIO, Inc.
05/26/2023 4 Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Porter Derrell (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Kamarck Michael E. (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 21,567 options to buy @ $1, valued at $21.6k
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/26/2023 4 Islam Saqib (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Countouriotis Athena (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Investor presentation, Quarterly results
Docs: "PASSAGE BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS"
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 ARS Form ARS - Annual Report to Security Holders:
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/06/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
04/05/2023 4 Chou William (President and CEO) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 608,615 options to buy @ $1.08, valued at $657.3k
04/05/2023 4 King Simona (CFO) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 140,000 options to buy @ $1.08, valued at $151.2k
04/05/2023 4 Forman Mark S (Chief Medical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
04/05/2023 4 Cale Edgar B. (GC & Corporate Secretary) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
04/05/2023 4 Fotopoulos Alexandros (Chief Technical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
04/03/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy